PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
4.87
P/E exceeding 1.5x Medical - Pharmaceuticals median of 1.04. Michael Burry would check for market euphoria. Scrutinize growth expectations.
0.53
P/S less than half the Medical - Pharmaceuticals median of 5.17. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
1.13
P/B 50-90% of Medical - Pharmaceuticals median of 1.73. Mohnish Pabrai would examine if this discount presents opportunity.
4.56
P/FCF of 4.56 versus zero FCF in Medical - Pharmaceuticals. Walter Schloss would verify cash flow quality.
3.79
P/OCF near Medical - Pharmaceuticals median of 4.05. Charlie Munger would verify if industry-standard multiples reflect business reality.
1.13
Fair value ratio 50-90% of Medical - Pharmaceuticals median of 1.73. Mohnish Pabrai would examine if this gap presents opportunity.
5.13%
Earnings yield exceeding 1.5x Medical - Pharmaceuticals median of 0.56%. Joel Greenblatt would investigate if high yield reflects hidden value.
21.91%
FCF yield of 21.91% versus zero FCF in Medical - Pharmaceuticals. Walter Schloss would verify cash flow quality.